Our results show that the average IGF1 was significantly higher among patients with liver metastasis, lymph node spread, and lymphovascular invasions and did not show a significant association with gender, smoking status, family history, or primary site of colorectal cancer. Here, IGF1 is linked to colorectal cancer.